Pulse Biosciences, Inc. (PLSE) Tops Q4 EPS by 7c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $264 thousand versus the consensus estimate of $750 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits